Hikma Pharmaceuticals (HIK.LSE) Q1 2026 Earnings

26FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
79.75
86.38
93.01
99.63

Details

Expected EPS
79.7513223
Actual EPS
N/A
Surprise EPS
-79.75
Surprise Percent
+100%

Description

Hikma Pharmaceuticals (HIK.LSE) will report earnings of for Q1 2026 on February 26, 2026.

0 Comments

Share your thoughts